Status
Conditions
Treatments
About
This study examines the impact of cognitive training among participants with ADHD in Switzerland
Full description
The main aim of the experimental study is to investigate cognitive functioning, behavioral and neural levels in ADHD, both before and after cognitive training where there has been the addition of motivation elements. Near and far transfers effects of this new program are evaluated. For far transfers, ambulatory assessment is used to improve ecological validity. Neural activity has rarely been examined in cognitive training with ADHD participants, and that is why this study also includes FMRI measures. Long-term effects, defined as three and six months following the completion of cognitive training, are also investigated. This study focuses on children, adolescents and adults with ADHD. Indeed, cognitive training effects have been rarely studied over the lifespan.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Participants fulfilling all of the following inclusion criteria are eligible for the study for the patients'group:
Participants fulfilling all of the following inclusion criteria are eligible for the study for the control group of healthy participants:
Exclusion criteria
The exclusion criteria for the participants in the patient's group are:
(7) FMRI exclusion: claustrophobia, Pregnancy known or suspected,metallic implants in their bodies (e.g: pacemakers, aneurism clips, metal Prosthetic, cochlear implant) (8) In case of suicidal risk, the participant is encouraged to consult the medical staff (9) Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant (10) Participation in another study on cognitive training (11) Previous enrolment into the current study (12) Enrolment of the investigator, his/her family members, employees and other dependent persons
The exclusion criteria for the participants in the control group of healthy participants are:
Primary purpose
Allocation
Interventional model
Masking
240 participants in 3 patient groups
Loading...
Central trial contact
amelie dentz, Ph.D; Chantal Martin Soelch, Pr
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal